jag009
★★★

NJ,
2018-05-24 05:26
(2156 d 09:12 ago)

Posting: # 18810
Views: 2,720
 

 FDA: Biowaiver on lower strengths [Regulatives / Guidelines]

Post reply
Hi guys and girls,

Question. When one does the f2 comparisons for a biowaiver on lower strengths, they are usually strength 1 vs RLD strength 2, strength 2 vs RLD strength 2, etc etc. If one passes these comparison but fails f2 for some of the lower strength vs highest strength comparison of the test products themselves, would that be an issue?

Thanks
John
 
wienui
★    

Germany/Oman,
2018-05-24 17:25
(2155 d 21:13 ago)

@ jag009
Posting: # 18813
Views: 2,243
 

 FDA: Biowaiver on lower strengths

Post reply
Hi John,

I'm afraid yes. As the lower test strength have to pass the in vitro comparative dissolution testing vs the high bio-batch (which pass the BE study vs the RLD) test strength.
regards,
Osama
—
Cheers,
Osama
 
Yura
★    

Belarus,
2018-05-25 12:22
(2155 d 02:16 ago)

@ jag009
Posting: # 18815
Views: 2,166
 

 FDA: Biowaiver on lower strengths

Post reply
Hi John,
The biowaiver for lower dosages (T1, T2) is administered with the dosage (T), which participated in the bioequivalent study.
with respect
 
Yura
★    

Belarus,
2018-05-26 19:21
(2153 d 19:17 ago)

@ Yura
Posting: # 18817
Views: 2,066
 

 FDA: Biowaiver on lower strengths

Post reply
Hi John,
...literature, ...justification, ...comparison with the same dose of the originator, ...other statistical approaches.
with respect
 
UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,664 registered users;
71 visitors (0 registered, 71 guests [including 4 identified bots]).
Forum time: 14:38 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5